Tetraphase Pharmaceuticals Inc (TTPH)

4.16
0.07 1.80
NASDAQ : Health Care
Prev Close 4.08
Open 4.08
Day Low/High 3.98 / 4.23
52 Wk Low/High 3.12 / 50.16
Volume 613.70K
Avg Volume 593.90K
Exchange NASDAQ
Shares Outstanding 36.61M
Market Cap 148.25M
EPS -2.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week of February 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

First Week of February 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

Investors in Tetraphase Pharmaceuticals, Inc saw new options begin trading this week, for the February 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data At ASM Microbe 2016

Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data At ASM Microbe 2016

Includes Phase 3 Clinical Trial Data from IGNITE1 and IGNITE2

Monsanto, Amazon and Apple: Doug Kass' Views

Monsanto, Amazon and Apple: Doug Kass' Views

Doug Kass shares his thoughts on shorting financials, and wonders if it will be a Monsanto merger Monday.

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

IMPORTANT DEADLINE REMINDER: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT DEADLINE REMINDER: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

EQUITY ALERT UPDATE: Rosen Law Firm Expands Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. On Behalf Of Options Purchasers And Sellers

EQUITY ALERT UPDATE: Rosen Law Firm Expands Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. On Behalf Of Options Purchasers And Sellers

Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of all purchasers of the common stock and call options and sellers of put options of Tetraphase Pharmaceuticals, Inc.

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Tetraphase Pharmaceuticals, Inc. And Urges Investors To Contact The Firm

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Tetraphase Pharmaceuticals, Inc. And Urges Investors To Contact The Firm

Lundin Law PC announces it is investigating claims against Tetraphase Pharmaceuticals, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tetraphase Pharmaceuticals Inc.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Tetraphase Pharmaceuticals Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals Reports Fourth-Quarter And Full-Year 2015 Financial Results And Provides Corporate Update

Tetraphase Pharmaceuticals Reports Fourth-Quarter And Full-Year 2015 Financial Results And Provides Corporate Update

- Company to Host Conference Call at 4:30 p.m. ET Today -

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016 - TTPH

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016 - TTPH

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Tetraphase Pharmaceuticals Inc.

What Carl Icahn Is Doing; Biotech Breakout: Best of Kass

What Carl Icahn Is Doing; Biotech Breakout: Best of Kass

Doug Kass looks at Carl Icahn's actions on Apple and the breakout in biotech stocks.